Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 448

1.

Temperature Sensitivity as a Microbial Trait Using Parameters from Macromolecular Rate Theory.

Alster CJ, Baas P, Wallenstein MD, Johnson NG, von Fischer JC.

Front Microbiol. 2016 Nov 17;7:1821.

2.

Peri- and postoperative management of stage I-III Non Small Cell Lung Cancer: Which quality of care indicators are evidence-based?

Numan RC, Berge MT, Burgers JA, Klomp HM, van Sandick JW, Baas P, Wouters MW.

Lung Cancer. 2016 Nov;101:129-136. doi: 10.1016/j.lungcan.2016.06.007. Review.

PMID:
27794401
3.

Pre- and postoperative care for stage I-III NSCLC: Which quality of care indicators are evidence-based?

Numan RC, Berge MT, Burgers JA, Klomp HM, van Sandick JW, Baas P, Wouters MW.

Lung Cancer. 2016 Nov;101:120-128. doi: 10.1016/j.lungcan.2016.05.022. Review.

PMID:
27794400
4.

Microtubules in health and degenerative disease of the nervous system.

Matamoros AJ, Baas PW.

Brain Res Bull. 2016 Sep;126(Pt 3):217-225. doi: 10.1016/j.brainresbull.2016.06.016.

PMID:
27365230
5.

The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.

Pass H, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, Asamura H, Waller D, Edwards J, Weder W, Hoffmann H, van Meerbeeck JP, Nowak A, Rusch VW; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions..

J Thorac Oncol. 2016 Dec;11(12):2082-2088. doi: 10.1016/j.jtho.2016.09.123.

PMID:
27670823
6.

The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.

Rice D, Chansky K, Nowak A, Pass H, Kindler H, Shemanski L, Opitz I, Call S, Hasegawa S, Kernstine K, Atinkaya C, Rea F, Nafteux P, Rusch VW; Mesothelioma Domain of the IASLC Staging and Prognostic Factors Committee, advisory boards and participating institutions..

J Thorac Oncol. 2016 Dec;11(12):2100-2111. doi: 10.1016/j.jtho.2016.09.121.

PMID:
27687964
7.

The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.

Nowak AK, Chansky K, Rice DC, Pass HI, Kindler HL, Shemanski L, Billé A, Rintoul RC, Batirel HF, Thomas CF, Friedberg J, Cedres S, de Perrot M, Rusch VW; Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions..

J Thorac Oncol. 2016 Dec;11(12):2089-2099. doi: 10.1016/j.jtho.2016.08.147.

PMID:
27687963
8.

The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.

Rusch VW, Chansky K, Kindler HL, Nowak AK, Pass HI, Rice DC, Shemanski L, Galateau-Sallé F, McCaughan BC, Nakano T, Ruffini E, van Meerbeeck JP, Yoshimura M; IASLC Staging and Prognostic Factors Committee, advisory boards, and participating institutions..

J Thorac Oncol. 2016 Dec;11(12):2112-2119. doi: 10.1016/j.jtho.2016.09.124.

PMID:
27687962
9.

P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment: Track: Immunotherapy.

Herbst RS, Baas P, Perez-Gracia JL, Felip E, Kim DW, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, Surmont V, De Castro G Jr, Garrido M, Shentu Y, Dolled-Filhart M, Im E, Garon EB.

J Thorac Oncol. 2016 Oct;11(10S):S242-S243. doi: 10.1016/j.jtho.2016.08.112. No abstract available.

PMID:
27676575
10.

PD1.06 (also presented as P2.41): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment.

Herbst RS, Baas P, Perez-Gracia JL, Felip E, Kim DW, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, Surmont V, De Castro G Jr, Garrido M, Shentu Y, Dolled-Filhart M, Im E, Garon EB.

J Thorac Oncol. 2016 Oct;11(10S):S174-S175. doi: 10.1016/j.jtho.2016.08.014. No abstract available.

PMID:
27676480
11.

New targeted treatments for non-small-cell lung cancer - role of nivolumab.

Zago G, Muller M, van den Heuvel M, Baas P.

Biologics. 2016 Aug 1;10:103-17. doi: 10.2147/BTT.S87878. Review.

12.

Scalariform-to-simple transition in vessel perforation plates triggered by differences in climate during the evolution of Adoxaceae.

Lens F, Vos RA, Charrier G, van der Niet T, Merckx V, Baas P, Aguirre Gutierrez J, Jacobs B, Chacon Dória L, Smets E, Delzon S, Janssens SB.

Ann Bot. 2016 Aug 7. pii: mcw151. [Epub ahead of print]

13.

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.

Salahudeen AA, Patel MI, Baas P, Curran WJ, Bradley JD, Gandara DR, Goss GD, Mok TS, Ramalingam SS, Vokes EE, Malik SM, Wakelee HA.

Clin Lung Cancer. 2016 Jun 27. pii: S1525-7304(16)30147-4. doi: 10.1016/j.cllc.2016.06.007. [Epub ahead of print] Review.

PMID:
27473736
14.

The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer.

Detterbeck FC, Chansky K, Groome P, Bolejack V, Crowley J, Shemanski L, Kennedy C, Krasnik M, Peake M, Rami-Porta R; IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions..

J Thorac Oncol. 2016 Sep;11(9):1433-46. doi: 10.1016/j.jtho.2016.06.028.

PMID:
27448762
15.

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

De Ruysscher D, Lueza B, Le Péchoux C, Johnson DH, O'Brien M, Murray N, Spiro S, Wang X, Takada M, Lebeau B, Blackstock W, Skarlos D, Baas P, Choy H, Price A, Seymour L, Arriagada R, Pignon JP; RTT-SCLC Collaborative Group..

Ann Oncol. 2016 Oct;27(10):1818-28. doi: 10.1093/annonc/mdw263. Review.

PMID:
27436850
16.

Phosphorus mobilizing consortium Mammoth P(™) enhances plant growth.

Baas P, Bell C, Mancini LM, Lee MN, Conant RT, Wallenstein MD.

PeerJ. 2016 Jun 14;4:e2121. doi: 10.7717/peerj.2121.

17.

Microtubules and Growth Cones: Motors Drive the Turn.

Kahn OI, Baas PW.

Trends Neurosci. 2016 Jul;39(7):433-40. doi: 10.1016/j.tins.2016.04.009. Review.

PMID:
27233682
18.

137O: Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profling analyses.

Lena H, Rizvi NA, Wolf J, Cappuzzo F, Zalcman G, Baas P, Mazieres J, Farsaci B, Blackwood-Chirchir MA, Ramalingam S.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S115-6. doi: 10.1016/S1556-0864(16)30247-7. No abstract available.

PMID:
27198275
19.

Depletion of kinesin-12, a myosin-IIB-interacting protein, promotes migration of cortical astrocytes.

Feng J, Hu Z, Chen H, Hua J, Wu R, Dong Z, Qiang L, Liu Y, Baas PW, Liu M.

J Cell Sci. 2016 Jun 15;129(12):2438-47. doi: 10.1242/jcs.181867.

20.

Sliding of centrosome-unattached microtubules defines key features of neuronal phenotype.

Rao AN, Falnikar A, O'Toole ET, Morphew MK, Hoenger A, Davidson MW, Yuan X, Baas PW.

J Cell Biol. 2016 May 9;213(3):329-41. doi: 10.1083/jcb.201506140.

Items per page

Supplemental Content

Loading ...
Support Center